Two different lung-specific bacterial chassis (MycoChassis and LactoChassis), designed to treat acute and chronic respiratory diseases, respectively. These chassis are able to expose antigens or deliver therapeutic agents in the lung in a controlled, local and continuous manner.
IMMUNE SYSTEM MODULATION
Immune stimulatory interleukins, nanobodies against immune check point inhibitors
Pulmonary alveolar proteinosis
ANTIMICROBIAL AND BIOFILM DISPERSION
FOR GENETIC DISEASES
Interstitial lung disease